Gilead Sciences revenue was $27.31 b in FY, 2021
Gilead Sciences revenue breakdown by business segment: 98.9% from Product Sales and 1.1% from Other
Gilead Sciences revenue breakdown by geographic segment: 70.6% from United States, 17.9% from Europe and 11.6% from Other
Q3, 2021 | FY, 2021 | Q1, 2020 | Q2, 2021 | FY, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | FY, 2019 | Q1, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Product Sales | 7.36 b | 27.01 b | 5.47 b | 6.15 b | 24.36 b | 5.07 b | 6.49 b | 6.34 b | 22.12 b | 6.53 b |
Royalty, Contract and Other Revenues | 65 m | 297 m | 81 m | 65 m | 334 m | 76 m | 84 m | 83 m | 330 m | 56 m |
Q3, 2021 | FY, 2021 | Q1, 2020 | Q2, 2021 | FY, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | FY, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Other | $881 m | $3.16 b | $567 m | $792 m | $2.34 b | $573 m | $540 m | $827 m | $1.99 b |
United States | $5.51 b | $19.27 b | $4.01 b | $4.23 b | $18.22 b | $3.78 b | $5.1 b | $4.26 b | $16.65 b |
Europe | $1.03 b | $4.87 b | $975 m | $1.19 b | $4.14 b | $786 m | $937 m | $1.34 b | $3.81 b |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.